Sukki Cho

Dr. Sukki Cho


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
SCSukki Cho
Sukki Cho
ISIn Hag Song
In Hag Song
HYHee Chul Yang
Hee Chul Yang
KKKwhanmien Kim
Kwhanmien Kim
SJSanghoon Jheon
Sanghoon Jheon

14 November 2013 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
YSYangki Seok
Yangki Seok
SCSukki Cho
Sukki Cho
JLJa Young Lee
Ja Young Lee
HYHee Chul Yang
Hee Chul Yang
KKKwhanmien Kim
Kwhanmien Kim
SJSanghoon Jheon
Sanghoon Jheon
Upper lobectomy inevitably leads to an upward displacement of the remaining lower lobe. Such displacement may result in bronchial angulation, thereby narrowing the airway. We hypothesized that the degree of displacement of the bronchus is associated with the degree of exacerbation of postoperative pulmonary dysfunction. This study investigated whether bronchial angulation affects postoperative pulmonary function. Patients undergoing upper lobectomy for lung cancer were retrospectively evaluated. A check for the presence of dyspnoea, pulmonary function test, chest X-ray and chest computed tomography (CT) were performed at 3 and 12 months postoperatively in these patients. The angle formed by the main bronchus and the bronchus intermedius on the right side and that by the main bronchus and the lower lobar bronchus were measured using the coronal view of the chest CT. We analysed the relationship between the change in bronchial angle and pulmonary function. Ninety-nine patients were enrolled in this study. Among these patients, 50 underwent left upper lobectomy (LUL) and 49 underwent right upper lobectomy (RUL). Nine patients who underwent LUL showed worsening symptoms, and among them, 8 presented an increase in the angle. However, among the 9 patients with worsening symptoms after RUL, only 4 presented an increase in the angle. Decreased forced expiratory volume in 1 s (FEV1) from 3 to 12 months after surgery was observed in 16 patients in the LUL group and 14 in the RUL group. Exacerbation of pulmonary dysfunction was associated with an increase in the bronchial angle (P = 0.04 for LUL and P = 0.02 for RUL). The degree of angle change was also associated with the extent of FEV1 reduction (P = 0.02 for LUL and P = 0.02 for RUL). Although the change in the bronchial angle is a physiological condition, it can reduce postoperative pulmonary function. The measurement of the change in the angle using the coronal view of a chest CT is a useful screening tool for predicting the postoperative reduction in FEV1.

1 October 2013 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
SCSukki Cho
Sukki Cho
HYHeeChul Yang
HeeChul Yang
KKKwhanmien Kim
Kwhanmien Kim
SJSanghoon Jheon
Sanghoon Jheon

Verified
Journal Article
Open access
PDF file
HSHye-Jin Sung
Hye-Jin Sung
JAJung-Mo Ahn
Jung-Mo Ahn
YYYeon-Hee Yoon
Yeon-Hee Yoon
SNSang-Su Na
Sang-Su Na
YCYoung-Jin Choi
Young-Jin Choi
JCJe-Yoel Cho
Je-Yoel Cho
As lung cancer shows the highest mortality in cancer-related death, serum biomarkers are demanded for lung cancer diagnosis and its treatment. To discover lung cancer protein biomarkers, secreted proteins from primary cultured lung cancer and adjacent normal tissues from patients were subjected to LC/MS–MS proteomic analysis. Quiescin sulfhydryl oxidase (QSOX1) was selected as a biomarker candidate from the enriched proteins in the secretion of lung cancer cells. QSOX1 levels were higher in 82% (51 of 62 tissues) of lung cancer tissues compared to adjacent normal tissues. Importantly, QSOX1 serum levels were significantly higher in cancer patients (p < 0.05, Area Under curve (AUC) = 0.89) when measured by multiple reaction monitoring (MRM). Higher levels of QSOX1 were also uniquely detected in lung cancer tissues, among several other solid cancers, by immunohistochemistry. QSOX1-knock-downed Lewis lung cancer (LLC) cells were less viable from oxidative stress and reduced migration and invasion. In addition, LLC mouse models with QSOX1 knock-down also proved that QSOX1 functions in promoting cancer metastasis. In conclusion, QSOX1 might be a lung cancer tissue-derived biomarker and be involved in the promotion of lung cancers, and thus can be a therapeutic target for lung cancers.

1 June 2014 in Journal of Thoracic Oncology
Verified
Journal Article
Open access
PDF file
YSYangki Seok
Yangki Seok
HYHee Chul Yang
Hee Chul Yang
TKTae Jung Kim
Tae Jung Kim
KLKyung Won Lee
Kyung Won Lee
KKKwhanmien Kim
Kwhanmien Kim
SCSukki Cho
Sukki Cho
Background: This study analyzed the relation between the tumor size and the lymph node metastasis in adenocarcinoma of the lung with a size of 30 mm or smaller. Methods: Four hundred thirteen patients who had undergone curative resection for lung adenocarcinoma were enrolled. If the tumor presented ground-glass opacities on the preoperative high-resolution computed tomography, both the total size including ground-glass opacities and the solid size alone were measured. To calculate the rates of lymph node metastasis by the tumor size, the tumors were divided into six groups by their sizes: 5 mm or less, 6 to 10 mm, 11 to 15 mm, 16 to 20 mm, 21 to 25 mm, and 26 to 30 mm. Results: The average numbers of dissected lymph nodes and dissected lymph node stations were 17 and 5, respectively. Seventy-five patients (18%) were postoperatively discovered to have positive nodes. The rates of node metastasis in each total size group were 0/1 (0%), 0/29 (0%), 5/77 (7%), 17/121 (14%), 27/101 (27%), and 26/84 (31%), respectively. The rates of node metastasis in each solid size group were 0/37 (0%), 1/53 (2%), 9/88 (10%), 17/104 (16%), 23/78 (30%), and 25/53 (47%), respectively. The area under the curve of receiver operating characteristic curves for the total size was measured as 0.701, and that for the solid size was measured as 0.777. By multivariate analysis, solid size, maximum standardized uptake value, and lymphovascular invasion were independent significant predictive factors. Conclusions: Solid size, maximum standardized uptake value, and lymphovascular invasion were independent predictors for lymph node metastasis of lung adenocarcinoma. The size of the solid component explained the relation between the tumor size and the lymph node metastasis more accurately than that explained by the total tumor size on high-resolution computed tomography.

27 June 2013 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
ISIn Hag Song
In Hag Song
SYSung Won Yeom
Sung Won Yeom
SHSeohee Heo
Seohee Heo
WCWon Suk Choi
Won Suk Choi
HYHee Chul Yang
Hee Chul Yang
SCSukki Cho
Sukki Cho
The clinical course from recurrence to cancer-related death after curative resection has not been clearly elucidated in non-small-cell lung cancer (NSCLC). This study examined the clinical outcomes after postoperative recurrence in patients with completely resected Stage I NSCLC. This study included patients who had recurrence after complete resection for pathological Stage I NSCLC between 2003 and 2009. Clinical data evaluated in this study included the diagnostic process of recurrence, recurrence pattern, treatment process and prognosis. A number of clinicopathological factors were analysed for post-recurrence survival by univariate and multivariate analyses. Seventy-two patients experienced recurrence during a median follow-up period of 37.5 months. Thirteen patients (18%) presented symptoms at the initial recurrence. Tumour markers, computed tomography (CT) and positron emission tomography/CT were chosen as the initial diagnostic tools and detected recurrences in 1 (1%), 51 (71%) and 7 (10%) patients, respectively. The mean recurrence-free interval (RFI) was 15.4 months (≤12 months in 34, >12 months in 38 patients). The patterns of recurrence were presented as loco-regional recurrence in 36 (50%) and distant metastasis in 36 patients (50%). Types of the initial treatment included operations in 28 (39%), chemotherapy and/or radiotherapy in 38 (53%) and radiofrequency ablation in 2 patients (3%). Four patients (6%) rejected treatment. Forty-three patients (62%) presented a good response to the initial treatment. Thirty-seven patients (51%) died, and the cause of death in all of these patients was cancer-related. The median survival duration after recurrence was 43.6 (1–136) months. Univariate analysis identified no recurrence of symptoms, a good response to treatment and a longer RFI as good prognostic factors, while a good response to treatment and a longer RFI were independent prognostic factors in multivariate analysis. Most postoperative recurrences were detected in an asymptomatic condition during the routine follow-up period, and a good response to initial treatment and a longer RFI were significant predictors of better post-recurrence survival in patients with completely resected Stage I NSCLC.